198
Participants
Start Date
February 28, 2011
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Fostamatinib
Fostamatinib 100mg twice daily.
Adalimumab
Adalimumab 40 mg by subcutaneous injection every 2 weeks for 24 weeks.
Placebo of Fostamatinib
Placebo bid for 6 weeks.
Placebo of Adalimumab
Placebo injection once every two weeks.
Research Site, Glendale
Research Site, Paradise Valley
Research Site, Phoenix
Research Site, Brooklyn
Research Site, Jackson
Research Site, Austin
Research Site, Pleven
Research Site, Mississauga
Research Site, Prague
Research Site, Hamburg
Research Site, Munich
Research Site, Balatonfüred
Research Site, Budapest
Research Site, Amsterdam
Research Site, Warsaw
Research Site, Yaroslavl
Research Site, Durban
Research Site, Pretoria
Research Site, Stellenbosch
Research Site, Manchester
Research Site, Oxford
Lead Sponsor
AstraZeneca
INDUSTRY